
    
      The aim of this protocol is to determine the non-inferiority of the effectiveness of
      sitagliptin compared to a control group of patients treated with thiazolidinediones as add-on
      therapy, in low-income ethnic minority type 2 diabetic patients who are failing to maintain
      adequate control with maximal doses of metformin and a sulfonylurea agent.
    
  